Loading…
MeiraGTx Holdings plc is projected to rise to $15.05 by 2027, a +28% move from its current price of $11.79. MGTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $11.45 | $11.80 | $12.16 | +0.07% |
| Aug 3 | $11.32 | $11.81 | $12.32 | +0.14% |
| Aug 4 | $11.22 | $11.81 | $12.44 | +0.21% |
| Aug 5 | $11.14 | $11.82 | $12.55 | +0.27% |
| Aug 6 | $11.07 | $11.83 | $12.65 | +0.34% |
| Aug 7 | $11.00 | $11.84 | $12.74 | +0.41% |
| Aug 8 | $10.95 | $11.85 | $12.82 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.95 | $11.85 | $12.82 | +0.48% |
| Week 2 | $10.64 | $11.90 | $13.31 | +0.96% |
| Week 3 | $10.43 | $11.96 | $13.72 | +1.45% |
| Week 4 | $10.26 | $12.02 | $14.08 | +1.94% |
| Week 5 | $10.12 | $12.08 | $14.41 | +2.43% |
| Week 6 | $10.00 | $12.13 | $14.73 | +2.92% |
| Week 7 | $9.89 | $12.19 | $15.03 | +3.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MeiraGTx Holdings plc is a clinical-stage genetic medicines company focused on developing treatments for patients with serious diseases. The company concentrates on ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia.
Its pipeline features AAV-based gene therapies, including AAV-AQP1 for radiation-induced xerostomia and Sjogren's syndrome; AAV-GAD in Phase 2 for Parkinson's disease; AAV-RPE65 in Phase 2 for RPE65-associated retinal dystrophy; and AAV-CNGB3 and AAV-CNGA3 in Phase 1/2 for achromatopsia, with AAV-AIPL1 for Leber congenital amaurosis (LCA) 4. The company also pursues preclinical programs such as AAV-RDH12 for retinal dystrophy and AAV-BBS10 for Bardet-Biedl syndrome, plus riboswitch platform and cell therapies for oncology, autoimmune disease, and long-term intractable pain.
MeiraGTx was founded in 2015 and is based in New York, New York. It also has programs for Alzheimer's disease, and wet and dry neovascular age-related macular degeneration, and collaborations with Johnson & Johnson Innovative Medicine and Hologen Limited.
MeiraGTx Holdings plc (MGTX) is a healthcare stock trading at $12.33, with a market cap of $1.14B and a rank of 2410.
Technical indicators show a bullish tilt in the price action, with RSI(14) at 50, and the stock trading above the SMA50 of $10.82 and above the SMA200 of $8.87. Support is noted at $9.00 and resistance at $14.66, framing a potential path for near-term moves. The 30-day range spans $9.75 to $15.59, reflecting a measured trading band.
Volatility remains elevated, at 70% annualized, underscoring the risk and swing potential around the current price. The long-run forecast envisions meaningful upside, with the 2026 avg price at $12.33 and progressively higher levels through 2030, 2040, and 2050.
A major floor 37.2% below — a decisive break under it would weaken the trend.
The nearest floor, 4.0% below — buyers have tended to step in here.
The nearest ceiling, 24.3% above — a clean break opens room to run.
A major ceiling 35.1% above — clearing it would confirm fresh momentum.
Key MGTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MGTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.90 | Sell | $11.89 | Sell |
| MA 10 | $12.03 | Sell | $12.04 | Sell |
| MA 20 | $12.62 | Sell | $12.14 | Sell |
| MA 50 | $11.34 | Buy | $11.52 | Buy |
| MA 100 | $10.18 | Buy | $10.56 | Buy |
| MA 200 | $9.08 | Buy | $9.48 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.16 | Neutral |
| Stoch RSI (14) | 21.63 | Neutral |
| CCI (20) | -79.96 | Neutral |
| Williams %R (14) | -81.91 | Info |
| MACD (12,26,9) | -0.19 | Sell |
| ROC (12) | -6.13 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 18.09 | Buy |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | -0.29 | Sell |
| Ultimate (7,14,28) | 43.11 | Neutral |
| Momentum (10) | -0.65 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 11.73 | Buy |
| ADX (14) | 13.88 | Neutral |
| ATR (14) | 0.35 | Info |
30-day picture: The stock trades within a $9.75–$15.59 window, suggesting a defined near-term range. The sentiment in the period is tagged as BULLISH, with the RSI at 50, indicating a neutral momentum punctuated by established support near $9.00 and resistance around $14.66.
Prices are supported by the SMA50 at $10.82 and the SMA200 at $8.87, which together with the defined support level provide a baseline for potential bounce scenarios if buyers re-emerge.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.99 | $11.79 | $16.84 | 0% | Neutral | |
| $11.90 | $15.05 | $20.20 | +28% | Bullish | |
| $14.63 | $19.09 | $26.67 | +62% | Bullish | |
| $16.46 | $22.05 | $31.79 | +87% | Bullish | |
| $19.74 | $27.04 | $40.03 | +129% | Bullish | |
| $25.78 | $36.06 | $54.62 | +206% | Bullish | |
| $30.25 | $43.15 | $66.72 | +266% | Bullish | |
| $34.42 | $49.99 | $78.74 | +324% | Bullish | |
| $36.13 | $53.40 | $85.56 | +353% | Bullish | |
| $37.80 | $56.81 | $92.47 | +382% | Bullish | |
| $68.46 | $110.99 | $192.98 | +841% | Bullish | |
| $123.86 | $229.14 | $438.36 | +18.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $6.99 | $11.79 | $14.93 | +0.00% |
| September 2026 | $10.52 | $12.48 | $15.26 | +5.88% |
| October 2026 | $10.50 | $12.55 | $15.52 | +0.54% |
| November 2026 | $10.88 | $13.09 | $16.34 | +4.30% |
| December 2026 | $11.06 | $13.38 | $16.84 | +2.20% |
Click any year to see its month-by-month MGTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MGTX price prediction for 2026 points to an average of $11.79 (low $6.99, high $16.84) — a potential gain of 0% on today's $11.79. A consolidation phase looks the most probable path here.
In 2027, MGTX is projected to trade between $11.90 and $20.20, averaging $15.05 — a potential gain of +28% from today's $11.79. That is up +28% on the projected 2026 average. Momentum favours further upside here.
MeiraGTx Holdings plc's 2028 outlook centres on $19.09, within a $14.63 to $26.67 range. That is up +27% on the projected 2027 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, MGTX could reach as high as $31.79, with a base case around $22.05 and support toward $16.46 — roughly +87% from $11.79. Momentum favours further upside here.
Expect MGTX to range from $19.74 to $40.03 through 2030. The $27.04 average target implies a +129% move from current prices. That is up +23% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The MGTX price prediction for 2031 points to an average of $36.06 (low $25.78, high $54.62) — a potential gain of +206% on today's $11.79. Momentum favours further upside here.
In 2032, MGTX is projected to trade between $30.25 and $66.72, averaging $43.15 — a potential gain of +266% from today's $11.79. That is up +20% on the projected 2031 average. Buyers look set to stay in control over this stretch.
MeiraGTx Holdings plc's 2033 outlook centres on $49.99, within a $34.42 to $78.74 range. That is up +16% on the projected 2032 average. That marks a +324% change versus current levels. Momentum favours further upside here.
By 2034, MGTX could reach as high as $85.56, with a base case around $53.40 and support toward $36.13 — roughly +353% from $11.79. Buyers look set to stay in control over this stretch.
Expect MGTX to range from $37.80 to $92.47 through 2035. The $56.81 average target implies a +382% move from current prices. That is up +6% on the projected 2034 average. Momentum favours further upside here.
The MGTX price prediction for 2040 points to an average of $110.99 (low $68.46, high $192.98) — a potential gain of +841% on today's $11.79. Buyers look set to stay in control over this stretch.
In 2050, MGTX is projected to trade between $123.86 and $438.36, averaging $229.14 — a potential gain of +18.4x from today's $11.79. That is up +106% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MGTX today (≈ 84.817642 MGTX) could be worth
$19,435.32
+$18,435.32 (+1844%) by 2050 · US Dollar
Based on the average projected MGTX price of $229.14 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MGTXwould be worth at today's price.
$1,000 invested in MGTX on Jul 31, 2025 (≈ 130.718953 MGTX) would be worth
$1,541.18
+$541.18 (+54.1%) today · 1.54× · US Dollar
Based on a MGTX entry price of $7.65 vs. today's $11.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.77 | $1,001.7 | +0.2% |
| 1 month ago | $12.8 | $921.09 | -7.9% |
| 3 months ago | $9.41 | $1,252.92 | +25.3% |
| 6 months ago | $7.83 | $1,505.75 | +50.6% |
| 1 year ago | $7.65 | $1,541.18 | +54.1% |
| All time (5.0y) ago | $13.62 | $865.64 | -13.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MGTX forecast.
Our base-case forecast reaches $24.00 around 2030.
Implied market cap at $24.00: $2.22B
The multi-year forecast shows a clear path of upside, with the average price rising from $12.33 in 2026 to $27.86 by 2030, and continuing higher to $113.56 by 2040 and $221.03 by 2050. The implied ROIs accelerate from 0% in 2026 to 125.9% in 2030, 821% in 2040, and 1692.7% in 2050, with bullish sentiment persisting across the longer horizon.
Key year-by-year highlights include 2027 avg $15.37 with 24.6% ROI, 2028 avg $20.09 with 62.9% ROI, 2029 avg $22.12 with 79.4% ROI, and 2035 avg $55.07 with 346.6% ROI. By 2040 the avg is $113.56 (max $210.09) and by 2050 the avg is $221.03 (max $454.74). These are estimates and not guarantees, and they reflect potential upside and the associated uncertainty.
Tap a question to reveal the answer.
min: $19.57, avg: $27.86, max: $42.99; ROI: 125.9%; sentiment: BULLISH.
The forecast shows bullish sentiment from 2027 onward, with 2027 avg $15.37 and rising through 2035 (avg $55.07) and beyond to 2040 and 2050, with ROIs up to 346.6% by 2035 and 1692.7% by 2050; note the 2026 figure shows neutral sentiment and 0% ROI, and these are estimates, not guarantees.
Yes. The 2040 max is $210.09, and the 2035 max is $94.60, indicating the potential to cross $100 by 2040.
Current price: $12.33. Market cap: $1.14B.
Low: $9.75, High: $15.59.
MeiraGTx Holdings plc Community Discussion
0Share your MeiraGTx Holdings plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.